Page last updated: 2024-12-06
iotasul
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
iotasul: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 71984 |
| CHEMBL ID | 2104394 |
| SCHEMBL ID | 38487 |
| MeSH ID | M0089482 |
Synonyms (24)
| Synonym |
|---|
| 71767-13-0 |
| D04592 |
| iotasul (usan/inn) |
| iotasul |
| 5-[3-[3-[3,5-bis[2,3-dihydroxypropyl(methyl)carbamoyl]-2,4,6-triiodoanilino]-3-oxopropyl]sulfanylpropanoylamino]-1-n,3-n-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-1-n,3-n-dimethylbenzene-1,3-dicarboxamide |
| zk 79 112 |
| 5,5'-(thiobis(ethylenecarbonylimino))bis(n,n-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-n,n'-dimethylisophthalamide) |
| iotasulum |
| 1,3-benzenedicarboxamide, 5,5'-(thiobis((1-oxo-3,1-propanediyl)imino))bis(n,n-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-n,n-dimethyl- |
| iotasulum [inn-latin] |
| iotasul [usan:inn] |
| 5fm9ux1ljb , |
| unii-5fm9ux1ljb |
| einecs 275-996-5 |
| zk 79112 |
| iotasul [inn] |
| iotasul [usan] |
| 1,3-benzenedicarboxamide, 5,5'-(thiobis((1-oxo-3,1-propanediyl)imino))bis(n,n'-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-n,n'-dimethyl- |
| iotasul [mart.] |
| zk-79-112 |
| zk-79112 |
| CHEMBL2104394 |
| SCHEMBL38487 |
| Q27261981 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (13)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 13 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Market Indicators
Research Demand Index: 11.74
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (11.74) All Compounds (24.57) |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 14 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||